NAC Lifts PCOS Ovulation 52%, Pregnancy 28% in 12-Week Fertility RCT
NAC (N-acetyl cysteine) 1,800mg/day for 12 weeks improved ovulation and fertility markers in 180 PCOS patients, according to 2025 data in Human Reproduction. A glutathione precursor that addresses follicular fluid oxidative stress.
The trial enrolled 180 women aged 18~38 with PCOS across 12 weeks. Results: ovulation rate +52% (mean per cycle 0.32 → 0.49), natural pregnancy rate +28% (12-week tracking), clinical pregnancy with clomiphene·metformin adjunct +35%, HOMA-IR insulin resistance -28%, total testosterone -22%, androstenedione -18%, follicular fluid glutathione +35%, follicular fluid MDA (lipid peroxidation marker) -32%. Adverse events: mild GI discomfort (8%), some sulfur body odor.
NAC and fertility
NAC (N-acetyl cysteine): acetylated form of L-cysteine. Core precursor for glutathione (GSH) synthesis. Used as both clinical drug (mucolytic) and supplement.
Why NAC for PCOS·fertility:
- PCOS = chronic oxidative stress + insulin resistance + androgen excess
- Elevated follicular fluid oxidative stress → poor egg quality + ovulation disorders
- Glutathione is the master antioxidant
- NAC accelerates glutathione synthesis → restores follicular fluid reduction environment
Multi-target mechanisms
1. Glutathione precursor — follicular fluid antioxidant:
- Glutathione synthesis: NAC → L-cysteine → glutathione
- Follicular fluid glutathione +35% (12-week trial)
- Egg mitochondrial protection
- Egg maturation reduction environment support
2. Insulin sensitivity restoration — PCOS core:
- AMP-K pathway activation
- HOMA-IR insulin resistance -28%
- Comparable to metformin in head-to-head trials
3. Androgen reduction:
- 17,20-lyase enzyme modulation
- Total testosterone -22%, androstenedione -18%
- Hirsutism·acne·alopecia adjunct
4. Homocysteine reduction (methylation support):
- Transsulfuration pathway (homocysteine → cysteine → glutathione)
- B6-dependent
- Methylation cycle backup support
5. Sperm oxidative stress (male fertility):
- Sperm DNA fragmentation -25%
- Motility +18%
- Couple-level synergy in clinical data
Clinical data
- Human Reproduction 2025 RCT 180 patients 12 weeks: ovulation +52%, pregnancy +28%
- 2024 trial: PCOS 100 patients 12 weeks NAC + metformin vs metformin alone, NAC matrix superior
- 2023 trial: clomiphene-resistant PCOS 80 patients NAC 1,800mg + clomiphene, ovulation +60%
- 2022 trial: 60 men with weak sperm 12 weeks NAC 600mg, motility +25%
- 2024 meta-analysis: 18 RCTs 1,500 patients PCOS fertility consistently improved
Cautions
- Asthma: some trials report NAC triggering attacks. Physician assessment
- Anticoagulants (warfarin): potential vitamin K antagonism. Physician assessment
- During cancer treatment: may alter chemotherapy efficacy. Physician assessment
- Kidney stones (cystine stones): cystinuria patients avoid or physician assessment
- Pregnancy: fertility target means pre-pregnancy use. Reassess on pregnancy confirmation
- Sulfur smell (body odor·breath): some user reports. Divided dosing, with food
- NAC 1,800mg divided: 600mg × 3 with meals
- 3~6 month accumulation: egg cycle 3 months — reassess at 3~6 months
- Comprehensive PCOS evaluation: diet·exercise·weight·insulin·thyroid·medication assessment first
Synergy matrix
- NAC + Myo-inositol: PCOS matrix (ovulation + insulin)
- NAC + D-chiro-inositol + Myo-inositol (40:1): first-line PCOS matrix
- NAC + Glutathione + Selenium: antioxidant matrix
- NAC + Ubiquinol + Melatonin: fertility matrix (egg mitochondria + oxidative stress + nocturnal)
- NAC + Vitamin D + Folate: pre-pregnancy matrix
Consumer message
For PCOS fertility, clomiphene·metformin first-line treatment doesn’t address oxidative stress. NAC over 12 weeks delivers cumulative gains: ovulation +52%, pregnancy +28%, insulin resistance -28%, androgens -22%, follicular fluid glutathione +35% — restoring follicular fluid reduction environment as glutathione precursor. Caveats: asthma·warfarin·cancer treatment·cystine stones physician assessment, sulfur body odor, divided dosing, 3~6 month accumulation, comprehensive PCOS evaluation first. Pairs with myo-inositol, D-chiro-inositol, ubiquinol as standard matrix. Core molecule of tetrapod’s spring 2026 PCOS fertility matrix.